B of A Securities Maintains Buy on Minimed Group, Raises Price Target to $28
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $24 to $28.
B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $24 to $28.